ArticleFrontiers in microbiology2025
High-yield astaxanthin production process development and scale-up validation from wild-type
Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study developed an integrated strategy to significantly enhance astaxanthin production from wild-type Methods: The research combined traditional parameter optimization with LSTM (Long Short-Term Memory) intelligent modeling. Systematic optimization of fermentation conditions was conducted in 500 mL bioreactors, followed by scale-up to 5 L systems. An innovative LSTM prediction model was constructed to predict astaxanthin concentration throughout the fermentation process. Results: Optimal fermentation conditions were determined as temperature 20°C, pH 4.5, and dissolved oxygen 20%, achieving an astaxanthin yield of 387.32 mg/L within 144 hours in 500 mL bioreactors. Upon scale-up to 5 L, the yield improved to 400.62 mg/L within 165 hours, demonstrating process robustness. The LSTM prediction model showed excellent performance with R Discussion: This research confirms the feasibility of achieving commercial-scale production of high-value natural astaxanthin through non-genetically modified approaches. The resulting product combines high productivity, safety, and regulatory advantages, providing an innovative solution for industrial-scale natural astaxanthin production that offers significant commercial potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.